Skip to main content
. 2005 May 3;92(10):1881–1891. doi: 10.1038/sj.bjc.6602592

Figure 2.

Figure 2

Telomerase activity in SK-N-MC cells treated with imatinib. (A) Telomeric repeat amplification protocol assay describing TA (one representative experiment). Imatinib concentrations are indicated above. R8: internal PCR control; N: negative control. (B) Quantification of TA affected by 15 μM imatinib (average of four independent assays). (C) Kinetics of TA affected by imatinib.